Europe Funds Alzheimer's, Brain Aging Systems Bio Consortium | GenomeWeb

NEW YORK (GenomeWeb News) – An international group of collaborators from academia and the business sector will partner to use integrative systems biology and comparative genomics approaches to study age-related human brain diseases with a particular focus on discovering new molecular targets and biomarkers for late-onset Alzheimer's disease.

The AgedBrainSYSBIO project, which is funded with €6 million ($7.7 million) from the European Commission, includes 14 partners in Belgium, France, Estonia, Germany, Israel, the UK, and Switzerland.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: RNA-seq, ChIP-seq to determine metformin response; array-based approach to detect protozoa in blood; and more.

Fast Company takes a look at startups in the nutrigenomic space that aim to offer personalized diet advice.

In a glamorous event, the Breakthrough Foundation gave out more than $25 million in prizes to researchers.

Immunotherapy might treat cancer, but it also appears to come with a risk of a number of side effects, the New York Times reports.